Search - tctmd.com

Displaying 401 - 420 of 4251

Sort: Relevancy | Date

News Features

Clots Found in the Left Atrial Appendage: A Big Deal for TAVR?

Todd Neale

June 27, 2016

News Industry News

BioVentrix Receives CE Marking Certification for Revivent TC™, the First Minimally Invasive Heart Failure Treatment to Restore the Left Ventricle

June 27, 2016

News Daily News

TAVR 后持续低流量主动脉瓣狭窄与较高的 1 年死亡率相关

Michael O'Riordan

June 23, 2016

News Daily News

Persistent Low-Flow Aortic Stenosis After TAVR Linked With Higher 1-Year Mortality

Michael O'Riordan

June 23, 2016

News Daily News

La Estenosis Aórtica Persistente de Bajo Flujo Post-TAVR se asocia a una Mortalidad Más Alta al cabo de 1 Año

Michael O'Riordan

June 23, 2016

Presentation

Evaluation of Flow After TAVR in PatientsWith Low-Flow Aortic Stenosis

Presenter: Venkatesh Anjan

June 22, 2016

News Industry News

Lombard Medical Announces CE Mark Approval for IntelliFlex™ LP Delivery System for the Aorfix™ Abdominal Aortic Aneurysm Endovascular Stent Graft

June 21, 2016

News Conference News TVT 2016

When Is Sick Too Sick for TAVR? Physicians Grapple With Identifying Futile Care

Michael O'Riordan

June 20, 2016

News Conference News TVT 2016

Valve Degeneration Data Dearth Spurs Calls for Universal Definitions and Clinical Guidance

Shelley Wood

June 20, 2016

News Conference News TVT 2016

Teenage TAVR: Should Practice Forge on While Guidelines Grow Up?

Michael O'Riordan

June 20, 2016

Presentation TVT 2016

CT Imaging for TAVR: Latest Techniques and What Can We Expect in the Future

Presenter: Jonathon A. Leipsic

June 18, 2016

Presentation TVT 2016

Case Presentation and Moderated Discussion

Presenter: Marian C. Hawkey

June 18, 2016

Presentation TVT 2016

Paravalvular Leak: Anticipated, Unexpected, and Therapy: Case Presentation (Two Examples)

Presenter: Mamoo Nakamura, MD

June 18, 2016

Presentation TVT 2016

Evolution From a TAVR Program to an Aortic Valve Center of Excellence

Presenter: A. Pieter Kappetein

June 18, 2016

Presentation TVT 2016

Aspects of Managing the Coronary Artery Preservation: Case Presentation (Two Examples)

Presenter: Susheel Kodali

June 18, 2016

Presentation TVT 2016

Surviving TAVR: Negotiating the Cost and Reimbursement Landscape

Presenter: Hemal Gada

June 18, 2016

Presentation TVT 2016

Undersizing/Oversizing: Therapy at the Margins for TAVR

Presenter: Danny Dvir

June 18, 2016

Presentation TVT 2016

Strategies for Program Growth: Meeting the Demands of New Indications Moving Parts and Evolving Processes for Growing Programs

Presenter: Susheel Kodali

June 18, 2016

Presentation TVT 2016

TEE: Guidance, Reassurance, or Both

Presenter: G. Burkhard Mackensen

June 18, 2016

Presentation TVT 2016

The Right Care for the Right Patient: Risk Stratification, Treatment Selection, and Postprocedure Pathways

Presenter: Sandra Lauck

June 18, 2016

Advertisement

Clots Found in the Left Atrial Appendage: A Big Deal for TAVR?

BioVentrix Receives CE Marking Certification for Revivent TC™, the First Minimally Invasive Heart Failure Treatment to Restore the Left Ventricle

TAVR 后持续低流量主动脉瓣狭窄与较高的 1 年死亡率相关

Persistent Low-Flow Aortic Stenosis After TAVR Linked With Higher 1-Year Mortality

La Estenosis Aórtica Persistente de Bajo Flujo Post-TAVR se asocia a una Mortalidad Más Alta al cabo de 1 Año

Evaluation of Flow After TAVR in PatientsWith Low-Flow Aortic Stenosis

Lombard Medical Announces CE Mark Approval for IntelliFlex™ LP Delivery System for the Aorfix™ Abdominal Aortic Aneurysm Endovascular Stent Graft

When Is Sick Too Sick for TAVR? Physicians Grapple With Identifying Futile Care

Valve Degeneration Data Dearth Spurs Calls for Universal Definitions and Clinical Guidance

Teenage TAVR: Should Practice Forge on While Guidelines Grow Up?

CT Imaging for TAVR: Latest Techniques and What Can We Expect in the Future

Case Presentation and Moderated Discussion

Paravalvular Leak: Anticipated, Unexpected, and Therapy: Case Presentation (Two Examples)

Evolution From a TAVR Program to an Aortic Valve Center of Excellence

Aspects of Managing the Coronary Artery Preservation: Case Presentation (Two Examples)

Surviving TAVR: Negotiating the Cost and Reimbursement Landscape

Undersizing/Oversizing: Therapy at the Margins for TAVR

Strategies for Program Growth: Meeting the Demands of New Indications Moving Parts and Evolving Processes for Growing Programs

TEE: Guidance, Reassurance, or Both

The Right Care for the Right Patient: Risk Stratification, Treatment Selection, and Postprocedure Pathways

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content